Defective regulation of IFNγ and IL-12 by endogenous IL-10 in progressive MS

Neurology

Volumn 55, Issue 2, 2000, Pages 192-198

  Balashov, K E ^a   Comabella, M ^a   Ohashi, T ^a   Khoury, S J ^a   Weiner, H L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; TH1 CELL; BLOOD; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE;

ADULT; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REFERENCE VALUES; TH1 CELLS;

EID: 0033623923     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.2.192     Document Type: Article

References (34)

1. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
2. + T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-38.
3. Del Prete G, De Carli M, Almerigogna F, et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-360.
4. Gerosa F, Paganin C, Peritt D, et al. Interleukin-12 primes human CD4 and CD8 T-cell clones for high production of both interferon-γ and interleukin-10. J Exp Med 1996;183:2559-2569.
5. Jeannin P, Delneste Y, Seveso M, et al. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol 1996;156:3159-3165.
6. Windhagen A, Anderson D, Carrizosa A, et al. IL-12 induces human T-cells secreting IL-10 with IFN-γ. J Immunol 1996; 157:1127-1131.
7. Moore KW, O'Garra A, de Waal Malefyt R, et al. Interleukin 10. Annu Rev Immunol 1993;11:165-190.
8. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-276.
9. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10: 153-187.
10. Beck J, Rondot P, Catinot L, et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988;78:318-323.
11. Panitch HS, Hirsch RL, Haley AS, et al. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987;1:893.
12. Woodroofe MN, Cuzner ML. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 1993;5:583-588.
13. Windhagen A, Newcombe J, Dangond F, et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182:1985-1996.
14. Noronha A, Toscas A, Jensen MA. Interferon b decreases T-cell activation and interferon γ production in multiple sclerosis. J Neuroimmunol 1993;46:145-153.
15. + T-cells via CD40 ligand. Proc Natl Acad Sci USA 1997;94:599-603.
16. Navikas V, Link J, Palasik W, et al. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand J Immunol 1995;41:171-178.
17. Monteyne P, Van Laere V, Marichal R, et al. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation. J Neuroimmunol 1997;80:137-142.
18. Crucian B, Dunne P, Friedman H, et al. Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients. Clin Diagn Lab Immunol 1995;2:766-769.
19. + T cell IL-10 production in stable relapsing multiple sclerosis. Int J Neurosci 1997;90:187-202.
20. Rieckmann P, Albrecht M, Kitze B, et al. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995;37:82-88.
21. Byskosh PV, Reder AT. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1996;1:262-269.
22. Mencacci A, Cenci E, Del Sero G, et al. IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J Immunol 1998;161: 6228-6237.
23. + T cell clones and peripheral blood T cells. J Immunol 1992;149:2378-2384.
24. + T cells. Immunology 1998;94:496-502.
25. Lu C-Z, Jensen M, Arnason B. Interferon gamma and IL-4 secreting cells in multiple sclerosis. J Neuroimmunol 1993;46: 123-128.
26. Link J, Soderstrom M, Olsson T, et al. Increased TGF beta, IL-4, and interferon gamma in multiple sclerosis. Ann Neurol 1994;36:379-386.
27. Nicoletti F, Patti F, Cocuzza C, et al. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J Neuroimmunol 1996;70:87-90.
28. Compston A, Ebers G, Lassmann H, McDonald I, Matthews WB, Wekerle H. McAlpine's multiple sclerosis. London: Churchill Livingstone, 1998.
29. Rook AH, Kubin M, Cassin M, et al. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol 1995;154:1491-1498.
30. DeKruyff RH, Gieni RS, Umetsu DT. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. J Immunol 1997;158:359-366.
31. Lester MR, Hofer MF, Gately M, et al. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis. J Immunol 1995;154:6174-6181.
32. Leung DY, Gately M, Trumble A, et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995;181: 747-753.
33. Comabella M, Balashov K, Issazadeh S, Smith D, Weiner HL, Khory SJ. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest 1998;102:671-678.
34. van Boxel-Dezaire AHH, Hoff SCJ, van Oosten BW, et al. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol 1999;45:695-703.